Although we need to move veterinary epilepsy classification forward we also must, as in human medicine, consider carefully whether any change of terminology is meaningful [ 5]; we must accept that currently we have not advanced the scientific understanding of the mechanisms leading to epilepsy in companion animals to the level applicable to the ILAE.
Thus, it is recommended to consider the ILAE Task Force proposal as a basis for seizure outcome classification in veterinary patients.
There are high levels of agreement between veterinary observers for the classification of (i) consciousness status, and the presence of (ii) motor signs, (iii) autonomic signs and (iv) neurobehavioural signs.
DSes described in veterinary literature according to classifications of Kiwiranta [ 32] and Bornard [ 14], their localization, and affected breeds are summarized in Table 1[ 9- 40].
The Anatomical Therapeutic Chemical classification system for veterinary medicinal products (ATCvet) was used for antimicrobial drug identification (WHOCC 2002).
In veterinary medicine, a number of classification proposals for canine epilepsy have been published over the years always reflecting in part the current ILAE proposals (e.g. [ 35– 35]).
Consequently, a meaningful progress in veterinary epilepsy pathology regarding diagnosis, classification and research can be achieved only if procedures and protocols are broadly available and manageable in a para-clinical setting.
In recent years, strong efforts have been made to classify and define epilepsy terms in veterinary medicine, in particular, the clinical classification of different seizure types has been advanced by the application of human medicine classification systems [ 2, 65, 134– 134].
This may be particularly important for veterinary and comparative pathologists, as the current classification is heavily weighted toward human lesions.
